Skip to main
CAPN
CAPN logo

Soleno Therapeutics (CAPN) Market Capitalization Overview

Market Cap: $80.50M as of Jun 12, 2025

$80.50M
Past Month+$313.20K (0.39%)
As of Jun 12, 2025, Soleno Therapeutics (CAPN) has a market capitalization of $80.50M. Over the past 30 days, its market cap has increased by 7.16%, while in the last 12 months, it has increased by 2.29%.

Market capitalization represents the total value of Soleno Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Soleno Therapeutics (CAPN) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Soleno Therapeutics (CAPN) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Soleno Therapeutics (CAPN) Market Cap History

DateMarket CapChange
Jun 2, 2025$80.18M+7.16%
May 1, 2025$74.83M+0.10%
Apr 1, 2025$74.75M-5.67%
Mar 3, 2025$79.24M+0.20%
Feb 3, 2025$79.09M+0.50%
Jan 2, 2025$78.70M+0.62%

Soleno Therapeutics (CAPN) End of Year Market Cap History

DateMarket CapChange
2025$80.50M+2.29%
2024$78.70M

FAQs About Soleno Therapeutics (CAPN) Market Cap

As of Jun 12, 2025, the market capitalization of Soleno Therapeutics (CAPN) is $80.50M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Soleno Therapeutics’s market capitalization has increased by 0.3900%, changing from $80.18M to $80.50M as of Jun 12, 2025.

In the last 3 months, Soleno Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Soleno Therapeutics’s market capitalization increased from – in January to $78.70M in December, reflecting a — change.

Soleno Therapeutics (CAPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.